Online Inquiry
Cat.#: ACPP-1341
| Despition | Pax2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1620 | Human SIX6 Protein (AC1620) | 5 µg | inquiry |
| ACPP-1790 | Rat MANF Protein (AC1790) | 5 µg | inquiry |
| ACPP-1685 | Human MOG Protein (AC1685) | 10 µg | inquiry |
| ACPP-1367 | Myocilin Blocking Peptide (AC1367) | 250 µg | inquiry |
| ACPP-1314 | Syndecan-1 Blocking Peptide (AC1314) | 250 µg | inquiry |
| ACPP-1407 | Human HOMER3 Protein (AC1407) | 5 µg | inquiry |
| ACPP-1342 | ORP150 Blocking Peptide (AC1342) | 250 µg | inquiry |
| ACPP-1732 | Human CHRNA6 Protein (AC1732) | 5 µg | inquiry |
| ACPP-1598 | Rat SIRPA Protein (AC1598) | 2 µg | inquiry |
| ACPP-1597 | Human CRYGS Protein (AC1597) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.